180 Life Sciences Statistics Share Statistics 180 Life Sciences has 153.03M
shares outstanding. The number of shares has increased by 441.95%
in one year.
Shares Outstanding 153.03M Shares Change (YoY) 441.95% Shares Change (QoQ) 75.18% Owned by Institutions (%) 99.99% Shares Floating 85.87M Failed to Deliver (FTD) Shares 183,767 FTD / Avg. Volume 1.87%
Short Selling Information The latest short interest is 6.87M, so 0% of the outstanding
shares have been sold short.
Short Interest 6.87M Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.27 and the forward
PE ratio is 0.12.
180 Life Sciences's PEG ratio is
0.
PE Ratio -0.27 Forward PE 0.12 PS Ratio 0 Forward PS 35.4 PB Ratio 0.18 P/FCF Ratio -1.13 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for 180 Life Sciences.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 1.47,
with a Debt / Equity ratio of 0.02.
Current Ratio 1.47 Quick Ratio 1.47 Debt / Equity 0.02 Debt / EBITDA -0.02 Debt / FCF -0.1 Interest Coverage -124.9
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.54M Employee Count 4 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -296.02K Effective Tax Rate 4.58%
Stock Price Statistics The stock price has increased by 261.03% in the
last 52 weeks. The beta is 0.41, so 180 Life Sciences's
price volatility has been higher than the market average.
Beta 0.41 52-Week Price Change 261.03% 50-Day Moving Average 2.96 200-Day Moving Average 1.79 Relative Strength Index (RSI) 41.92 Average Volume (20 Days) 9,833,114
Income Statement
Revenue n/a Gross Profit -58.28K Operating Income -6.32M Net Income -6.17M EBITDA -6.32M EBIT -6.51M Earnings Per Share (EPS) -15.49
Full Income Statement Balance Sheet The company has 4.59M in cash and 154.5K in
debt, giving a net cash position of 4.43M.
Cash & Cash Equivalents 4.59M Total Debt 154.5K Net Cash 4.43M Retained Earnings -141.52M Total Assets 10.71M Working Capital -2.24M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -1.48M
and capital expenditures 0, giving a free cash flow of -1.48M.
Operating Cash Flow -1.48M Capital Expenditures n/a Free Cash Flow -1.48M FCF Per Share -1.62
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields ATNF does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ATNF.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Feb 28, 2024. It was a
backward
split with a ratio of 1:19.
Last Split Date Feb 28, 2024 Split Type backward Split Ratio 1:19
Scores Altman Z-Score 99 Piotroski F-Score 2
